Skip to main content
OpenTrials
Completed

NCT Number: NCT06660875

Comparison of Postoperative Analgesic Efficacy of SPSIPB and Combination of IBPB and SCPB

Shoulder arthroscopy is one of the frequently performed surgical procedures today. After shoulder surgery, ensuring sufficent analgesia is necessary for both the patient's comfort and for the early and regular performance of the required postoperative rehabilitation exercises. Nerve blocks provide better pain control, opioid consumption in the postoperative period, and consequently have advantages such as fewer side effects and lower risks of pulmonary and cardiac complications. Multimodal analgesia approach is preferred for patients undergoing shoulder arthroscopy. Along with intravenous analgesic agents, peripheral nerve blocks (applied to every suitable and consenting patient) are performed based on patient preference. This study aims to compare the analgesic efficacy in the postoperative period of patients undergoing shoulder arthroscopy with a combination of interscalene brachial plexus block and superficial cervical plexus block with serratus posterior superior intercostal plane block.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ankara Etlik City Hospital

Yenimahalle, Ankara, 06170, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 to 65 years old
  • American Society of Anesthesiologists (ASA) physical status I-II-III
  • Body mass index 18 to 30 kg/m2
  • Elective shoulder arthroscopy surgery

Exclusion criteria

  • Under 18 and over 65
  • ASA score IV and above
  • Advanced co-morbidity
  • History of bleeding diathesis
  • BMI under 18 kg/m2 and over 30 kg/m2
  • Patient refusing the procedure
  • Patients who have previously undergone shoulder surgery
  • Chronic opioid or analgesic use
  • Patients who will operate under emergency conditions
  • Patients who will not undergo shoulder surgery

Treatment and study plan

Serratus posterior superior intercostal plane block

Drug

Serratus posterior superior intercostal plane block is performed, under US guidance, before the surgical operation, and the induction of anesthesia, and when the patient is placed in the prone position.

Interscalene brachial plexus block and superficial cervical plexus block

Drug

İnterscalene brachial plexus block and superficial cervical plexus block is performed, under US guidance, before the surgical operation, and the induction of anesthesia, and when the patient is placed in the prone position.

Primary outcomes

  1. Intraoperative remifentanil consumption

    Time frame: During The intraoperatif period

    The amount of remifentanil that patients need to maintain anesthesia during the intraoperative period will be recorded

Secondary outcomes

  1. Pain scores

    Time frame: First 24 hours after surgery

    Pain will be assessed at rest and while movement using the from 0 (no pain) to 10 (worst pain). Pain assessment will be done at the 1st, 2nd, 4th, 12th, and 24th hours after surgery

Sponsors and collaborators

Lead sponsor

Ankara Etlik City Hospital

Other Gov

Registry information

Official study title

Comparison of Postoperative Analgesic Efficacy of Serratus Posterior Superıor Intercostal Plane Block and Combination of Interscalene Brachial Plexus Block and Superfisial Plexus Block in Shoulder Arthroscopies

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Oct 28, 2024
Registry last updated
Jul 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.